A Real-World Study of Early Breast Cancer Patients Eligible for Treatment With CDK4/6 Inhibitors
Clinical trial NCT07647042 · COMPLETED
Trial details
- NCT number
- NCT07647042
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2026-03-31
- Primary completion
- 2026-04-30
- Enrollment
- 750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.